Stevie Yu

Cooley advised Reverence Capital Partners’ portfolio company Transact Campus, an innovative campus technology and payment solutions company, on a definitive agreement signed by Reverence Capital Partners to sell Transact to Roper Technologies for $1.6 billion.

Cooley advised Blue Owl Capital (NYSE: OWL), a top asset manager that is redefining alternatives, and HealthCare Royalty (HCRx), a top royalty acquisition company focused on commercial or near-commercial biopharmaceutical products, on a $250 million term loan facility with TG Therapeutics (NASDAQ: TGTX), a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.

Cooley advised Talkiatry, a top provider of high-quality, in-network psychiatric care, on its $130 million equity and debt financing round.

Cooley advised Vivid Seats in connection with a repricing and incremental amendment to its credit agreement. Pursuant to the amendment, Vivid Seats refinanced all term loans outstanding immediately prior to the effectiveness of the amendment and incurred $125.5 million in additional term loans. The aggregate principal amount of term loans outstanding immediately after giving effect to the amendment was $395 million. Vivid Seats, which trades on the Nasdaq Global Select Market under the symbol SEAT, is an online ticket marketplace committed to becoming the ultimate partner for connecting fans to live events, artists and teams. Partner Michael Tollini led the Cooley team.

Cooley advised Alarm.com Holdings, a platform for the intelligently connected property, on its $500 million convertible note offering.